Fundz

VentureMed Group Closes $28M Series C Funding Led by S3 Ventures to Accelerate Adoption of the FLEX VPTM System.

PRIVATEOct 29, 2025

Amount Raised

$28 Million

Round Type

Series C

PlymouthHealthcareHealth Care

Investors

Endeavour VisionS3 Ventures

Description

VentureMed Group, Inc. has secured $28 million in a Series C funding round led by S3 Ventures, with participation from existing investors like Endeavour Vision. This financing will enhance their commercial infrastructure and support new product development. The funds will advance the clinical program focusing on vascular care solutions

Quick answer

VentureMed Group raised $28 Million in a Series C round, dated October 29, 2025. Investors: Endeavour Vision and S3 Ventures. VentureMed Group is based in Plymouth, Minnesota, United States.

How much did VentureMed Group raise?
VentureMed Group raised $28 Million in a Series C round on October 29, 2025.
Who invested in VentureMed Group?
Endeavour Vision and S3 Ventures are named as investors in this round.
What does VentureMed Group do?
VentureMed Group, Inc. is a pioneering privately held medical device company based in Minnesota dedicated to advancing endovascular solutions for arteriovenous (AV) access and peripheral vascular disease interventions.
Where is VentureMed Group based and how big is it?
VentureMed Group is based in Plymouth, Minnesota, United States. Fundz records about 32 employees.
Who are the decision-makers at VentureMed Group?
Fundz holds 3 contacts at VentureMed Group. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Health Care around the same time

Companies in the same sectors as VentureMed Group that raised within 45 days of this round, from Fundz verified event records.

  • Enveric Biosciences raised $107K on December 12, 2025.
  • Sober Sidekick raised $7.6M (Funding Round) on December 9, 2025.
  • LivFul raised $250K on December 8, 2025.
  • INVO Fertility, Inc. raised $4M (Post-IPO Equity) on December 5, 2025.
  • Oncotelic Therapeutics raised $275K on December 4, 2025.
  • BioIntelliSense raised $58M on December 4, 2025.

Who to call at VentureMed Group, and when

A new round usually means VentureMed Group is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day VentureMed Group raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at VentureMed Group, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at VentureMed Group. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

VentureMed Group

Location

2800 Campus Drive Suite 50

Plymouth, Minnesota, United States

About

VentureMed Group, Inc. is a pioneering privately held medical device company based in Minnesota dedicated to advancing endovascular solutions for arteriovenous (AV) access and peripheral vascular disease interventions. The company's flagship technology, the FLEX Vessel Prep™ System, is an FDA 510(k)-cleared and CE Mark-approved device, that is designed to optimize vessel preparation using its proprietary Kinetic Endovascular Micro-incision Creation (KEMIC) technology. Unlike traditional balloon-based approaches that apply static pressure, KEMIC leverages controlled motion and dynamic vessel apposition to create long, precise 2 micro-incisions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment VentureMed Group raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Predictive Intelligence
Strategic

ML-powered predictions for VentureMed Group's next move

See what Strategic adds

VentureMed Group raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.